Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
6.44
+0.01 (0.16%)
At close: Apr 28, 2026, 4:00 PM EDT
6.45
+0.01 (0.16%)
After-hours: Apr 28, 2026, 7:55 PM EDT
Minerva Neurosciences Employees
Minerva Neurosciences had 7 employees as of December 31, 2025. The number of employees decreased by 1 or -12.50% compared to the previous year.
Employees
7
Change (1Y)
-1
Growth (1Y)
-12.50%
Revenue / Employee
n/a
Profits / Employee
-$41,917,597
Market Cap
282.34M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Abeona Therapeutics | 226 |
| LENZ Therapeutics | 152 |
| Coherus Oncology | 147 |
| AC Immune | 122 |
| Zentalis Pharmaceuticals | 106 |
| C4 Therapeutics | 104 |
| Editas Medicine | 87 |
NERV News
- 26 days ago - Minerva Announces Leadership Transition - GlobeNewsWire
- 4 weeks ago - Minerva Neurosciences Announces First Patient Screened in Global Phase 3 Confirmatory Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia - GlobeNewsWire
- 4 weeks ago - Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026 - GlobeNewsWire
- 5 weeks ago - Minerva Neurosciences Transcript: Stifel 2026 Virtual CNS Forum - Transcripts
- 6 weeks ago - Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum - GlobeNewsWire
- 6 weeks ago - Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates - GlobeNewsWire
- 7 weeks ago - Minerva Neurosciences Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - Minerva Neurosciences to Participate in The Citizens Life Sciences Conference - GlobeNewsWire